Degarelix Vs. Leuprolide Treatment in Patients With Advanced Prostate Cancer: Psa Failures During a Randomised, Phase Iii Trial (cs21)

Tombal, Bertrand;Miller, K.;Boccon-Gibod, L.;Schroder, F.;Persson, B-E;et.al.
(2009)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 510.27 KB
Request a copy

Details

Authors
  • Tombal, Bertrandorcid-logoUCLouvain
    Author
  • Miller, K.
    Author
  • Boccon-Gibod, L.
    Author
  • Schroder, F.
    Author
  • Persson, B-E
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Tombal, B., Miller, K., Boccon-Gibod, L., Schroder, F., Jensen, J. K., Olesen, T. K., & Persson, B.-E. (2009). Degarelix Vs. Leuprolide Treatment in Patients With Advanced Prostate Cancer: Psa Failures During a Randomised, Phase Iii Trial (cs21). European Urology Supplements, 8(4), 130. https://doi.org/10.1016/S1569-9056(09)60046-4 (Original work published 2009)